Fluticasone Propionate and Fluticasone Propionate/Salmeterol Compared to FLOVENT® DISKUS® and ADVAIR® DISKUS®
- Study Title
- Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENTֲ® DISKUSֲ® and ADVAIRֲ® DISKUSֲ® in Patients With Persistent Asthma 12 Years of Age and Older
- Teva Identifier
- FSS-AS-10042
- ClinicalTrials.gov Identifier
- NCT02437604
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Treatment A: Fp MDPI | Drug: Treatment B: FS MDPI | Drug: Treatment C Flovent | Drug: Treatment D: Advair
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 05/01/2015 - 09/01/2015
- Phase
- Phase 1